The University of Chicago Header Logo

Connection

Kathleen Mullane to Myelodysplastic Syndromes

Back to Details
This is a "connection" page, showing publications Kathleen Mullane has written about Myelodysplastic Syndromes.
Kathleen Mullane
Connection Strength
0.029
Myelodysplastic Syndromes
  1. Pharmacokinetics and safety results from the Phase 3 randomized, open-label, study of intravenous posaconazole in patients at risk of invasive fungal disease. J Antimicrob Chemother. 2017 Dec 01; 72(12):3406-3413.
    View in: PubMed
    Score: 0.029
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.